Literature DB >> 8861543

Opioid analgesics: comparative features and prescribing guidelines.

N I Cherny1.   

Abstract

The term 'opioid' is a generic term for naturally occurring, semisynthetic and synthetic drugs which combine with opioid receptors to produce physiological effects and which are stereospecifically antagonised by naloxone. For clinical purposes, opioids can be classified according to their receptor interactions (agonist, partial agonist, agonist-antagonist and antagonist), the pain intensity for which they are conventionally used (moderate or severe), and their half-life (short or long). Pure agonists conventionally used for moderate pain, short and long half-life pure agonists conventionally used for severe pain, mixed agonist-antagonists and partial agonist opioids are described in detail. The effective clinical use of opioid drugs requires familiarity with drug selection, routes of administration, dosage guidelines and potential adverse effects. Opioids are unequivocally indicated in the management of severe acute pain and moderate to severe pain associated with cancer. There is increasing acceptance of the role of opioids in the management of recurring acute pain, chronic nonmalignant pain of organic origin and severe neuropathic pain. The selection of opioids is influenced by pain intensity, pharmacokinetic and formulary considerations, previous adverse effects and the presence of coexisting disease. Some patients will require sequential trials of several different opioids before a drug which is effective and well tolerated is identified. Opioid agents should be administered by the most comfortable and convenient route that meets the specific needs of the patient. The regimen for opioid medications should generally provide around-the-clock analgesia with provision for rescue doses for the management of exacerbations of the pain not covered by the regular dosage. At all times, uncontrolled pain should be addressed by gradual increase in the opioid dose until either pain control is achieved or intolerable and unmanageable adverse effects supervene. The management of pain with opioid analgesics demands frequent patient assessment and a readiness to re-evaluate the therapeutic plan in the setting of either inadequate relief or adverse effects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8861543     DOI: 10.2165/00003495-199651050-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  176 in total

Review 1.  Cancer pain relief and palliative care. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1990

2.  Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer.

Authors:  E Bruera; C Brenneis; A H Paterson; R N MacDonald
Journal:  J Pain Symptom Manage       Date:  1989-03       Impact factor: 3.612

3.  A comparison of the analgesic effects of pentazocine and morphine in patients with cancer.

Authors:  W T Beaver; S L Wallenstein; R W Houde; A Rogers
Journal:  Clin Pharmacol Ther       Date:  1966 Nov-Dec       Impact factor: 6.875

4.  Chronic opioid therapy as alternative treatment for post-herpetic neuralgia.

Authors:  M Pappagallo; J N Campbell
Journal:  Ann Neurol       Date:  1994       Impact factor: 10.422

5.  The need for an open mind about the treatment of chronic nonmalignant pain.

Authors:  M M Reidenberg; R K Portenoy
Journal:  Clin Pharmacol Ther       Date:  1994-04       Impact factor: 6.875

6.  Use of intraventricular and intrathecal morphine in intractable pain associated with cancer.

Authors:  G Nurchi
Journal:  Neurosurgery       Date:  1984-12       Impact factor: 4.654

7.  Dextroamphetamine with morphine for the treatment of postoperative pain.

Authors:  W H Forrest; B W Brown; C R Brown; R Defalque; M Gold; H E Gordon; K E James; J Katz; D L Mahler; P Schroff; G Teutsch
Journal:  N Engl J Med       Date:  1977-03-31       Impact factor: 91.245

Review 8.  [Morphine-induced hyperalgesia, allodynia and myoclonus--new side-effects of morphine?].

Authors:  L S Jacobsen; A K Olsen; P Sjøgren; N H Jensen
Journal:  Ugeskr Laeger       Date:  1995-06-05

9.  Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.

Authors:  R B Raffa; E Friderichs; W Reimann; R P Shank; E E Codd; J L Vaught
Journal:  J Pharmacol Exp Ther       Date:  1992-01       Impact factor: 4.030

10.  Morphine pharmacokinetics and effects on salivation and continuous reaction times in healthy volunteers.

Authors:  D Westerling; L Frigren; P Höglund
Journal:  Ther Drug Monit       Date:  1993-10       Impact factor: 3.681

View more
  21 in total

1.  Trends in consumption of opioid analgesics in Slovak Republic during 1998-2002.

Authors:  R Hudec; J Tisonová; L Bozeková; V Foltán
Journal:  Eur J Clin Pharmacol       Date:  2004-07-01       Impact factor: 2.953

2.  Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness.

Authors:  J Zhang; S S Ferguson; L S Barak; S R Bodduluri; S A Laporte; P Y Law; M G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

3.  Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy.

Authors:  Christos Tsoukas; M Elaine Eyster; Sumiko Shingo; Saurabh Mukhopadhyay; Karen M Giallella; Sean P Curtis; Alise S Reicin; Agustin Melian
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

Review 4.  Responsible prescribing of opioids for the management of chronic pain.

Authors:  Bruce Nicholson
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 5.  Modulation of nociception by social factors in rodents: contribution of the opioid system.

Authors:  Francesca R D'Amato; Flaminia Pavone
Journal:  Psychopharmacology (Berl)       Date:  2012-09-20       Impact factor: 4.530

Review 6.  Opioid-induced bowel dysfunction: epidemiology, pathophysiology, diagnosis, and initial therapeutic approach.

Authors:  Spencer Dorn; Anthony Lembo; Filippo Cremonini
Journal:  Am J Gastroenterol Suppl       Date:  2014-09-10

7.  Obesity has no effect on outcomes following unicompartmental knee arthroplasty.

Authors:  Johannes F Plate; Marco A Augart; Thorsten M Seyler; Daniel N Bracey; Aneitra Hoggard; Michael Akbar; Riyaz H Jinnah; Gary G Poehling
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-04-12       Impact factor: 4.342

Review 8.  Levorphanol: the forgotten opioid.

Authors:  Eric Prommer
Journal:  Support Care Cancer       Date:  2006-10-13       Impact factor: 3.603

Review 9.  Tramadol: a review of its use in perioperative pain.

Authors:  L J Scott; C M Perry
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

10.  Behavioral and neurochemical changes induced by oxycodone differ between adolescent and adult mice.

Authors:  Yong Zhang; Roberto Picetti; Eduardo R Butelman; Stefan D Schlussman; Ann Ho; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2008-09-10       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.